TIME COURSE OF CHANGES IN OPTIC DISK NEOVASCULARIZATION AFTER A SINGLE INTRAVITREAL BEVACIZUMAB INJECTION

被引:9
|
作者
Falavarjani, Khalil Ghasemi [1 ]
Habibi, Abbas [1 ]
Khorasani, Maryam Ashraf [1 ]
Anvari, Pasha [1 ]
Sadda, Srinivas R. [2 ,3 ]
机构
[1] Iran Univ Med Sci, Rassoul Akram Hosp, Dept Ophthalmol, Eye Res Ctr, Tehran, Iran
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA
[3] Doheny Eye Inst, 1355 San Pablo St, Los Angeles, CA 90033 USA
关键词
bevacizumab; diabetic retinopathy; neovascularization; NVD; optical coherence tomography angiography; PROLIFERATIVE DIABETIC-RETINOPATHY; COHERENCE TOMOGRAPHY-ANGIOGRAPHY; ENDOTHELIAL GROWTH-FACTOR; AVASTIN;
D O I
10.1097/IAE.0000000000002107
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate the longitudinal changes in optic disk neovascularization (NVD) after intravitreal bevacizumab injection using optical coherence tomography angiography. Methods: In this prospective, interventional, case series, eyes with NVD secondary to diabetic retinopathy were enrolled. En face optical coherence tomography angiographic images were obtained from the optic disks before and 3 hours, 6 hours, 24 hours, 7 days, and 30 days after intravitreal bevacizumab injection. The size and flow area of the neovascularization were measured by two graders. Results: Eleven eyes of 9 patients with a mean age of 52.11 +/- 9.48 years were included. The reduction in the NVD size and flow area was statistically significant at 24 hours, 7 days, and 30 days after injections compared with the baseline measurements (all P < 0.05). The decremental regression in the NVD size and flow area continued during the study course. The changes were not statistically significant in 3-hour and 6-hour measurements (all P > 0.05). Conclusion: In this study, statistically significant regression in the NVD size and flow area was observed as early as 24 hours after a single intravitreal bevacizumab injection, with a continued decreasing trend for at least a 1-month period.
引用
收藏
页码:1149 / 1153
页数:5
相关论文
共 50 条
  • [41] Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma
    Batioǧlu F.
    Astam N.
    Özmert E.
    International Ophthalmology, 2008, 28 (1) : 59 - 61
  • [42] Changes in anterior segment morphology after intravitreal injection of bevacizumab and bevacizumab-triamcinolone acetate combination
    Alkin, Zeynep
    Perente, Irfan
    Altan, Cigdem
    Konstantinidis, Aristeidis
    Ozkaya, Abdullah
    Yuksel, Kemal
    Yazici, Ahmet Taylan
    Demirok, Ahmet
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2013, 23 (04) : 504 - 509
  • [43] Clinical Course of Choroidal Neovascularization Secondary to Angioid Streaks Treated With Intravitreal Bevacizumab
    Teixeira, Anderson
    Mattos, Tessa
    Velletri, Roberta
    Teixeira, Rafael
    Freire, Juliana
    Moares, Nilva
    Bonomo, Pedro Paulo
    OPHTHALMIC SURGERY LASERS & IMAGING, 2010, 41 (05) : 546 - 549
  • [44] Structural changes of choroidal neovascularization in indocyanine green angiography after intravitreal ranibizumab injection
    Kim, Hyun Woong
    Lee, Ji Eun E.
    Lee, Sang Joon
    Lee, Joo Eun
    Yun, Il Han
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [45] Severe Corneal Changes following Intravitreal Injection of Bevacizumab
    Bayar, Sezin Akca
    Altinors, Dilek D.
    Kucukerdonmez, Cem
    Akova, Yonca A.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2010, 18 (04) : 268 - 274
  • [46] Regression of optic nerve head neovascularization in proliferative diabetic retinopathy after intravitreal triamcinolone: Regression of diabetic optic disc neovascularization after intravitreal Triamcinolone
    Karacorlu M.
    Ozdemir H.
    Karacorlu S.
    Alacalı N.
    International Ophthalmology, 2004, 25 (2) : 113 - 116
  • [47] Functional and Anatomic Changes in Bilateral Choroidal Neovascularization Associated with Vitelliform Macular Dystrophy After Intravitreal Bevacizumab
    Cennamo, Gilda
    Cesarano, Ida
    Vecchio, Elisabetta Chiariello
    Reibaldi, Michele
    de Crecchio, Giuseppe
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2012, 28 (06) : 643 - 646
  • [48] Intravitreal bevacizumab injection in patients with choroidal neovascularization due to choroid rupture after blunt-head trauma
    Artunay O.
    Rasier R.
    Yuzbasioglu E.
    Sengül A.
    Bahcecioglu H.
    International Ophthalmology, 2009, 29 (4) : 289 - 291
  • [49] Macular detachment after successful intravitreal bevacizumab for myopic choroidal neovascularization
    Shimada, Noriaki
    Ohno-Matsui, Kyoko
    Hayashi, Kengo
    Yoshida, Takeshi
    Tokoro, Takashi
    Mochizuki, Manabu
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2011, 55 (04) : 378 - 382
  • [50] Regression of retinal and iris neovascularization after intravitreal bevacizumab (avastin) treatment
    Avery, Robert L.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (03): : 352 - 354